Navigation Links
Pacira Pharmaceuticals, Inc. Reports Second Quarter 2011 Financial Results
Date:8/11/2011

at the Society for Ambulatory Anesthesia's (SAMBA) 26th Annual Meeting. The data demonstrated that when the pain score and the opioid usage were combined using the integrated rank analysis of Silverman, statistical significance was achieved at multiple time points (p<0.05) and the mean total amount of opioid rescue used (morphine equivalents) was lower with EXPAREL at all time points through 96 hours.
  • Presented new Phase 3 EXPAREL data on subjects undergoing hemorrhoidectomy: In May 2011 new data from the Phase 3 study evaluating EXPAREL in patients following hemorrhoidectomy was presented at the 2011 American Society of Colon and Rectal Surgeons (ASCRS) Annual Scientific Meeting. Results from this study demonstrated that patients experienced less pain and a reduction in opioid use for 72 hours following a single injection of EXPAREL and that the median time to first opioid rescue was 14 hours and 20 minutes in the EXPAREL group compared to one hour and 10 minutes in the placebo group  (p<0.0001).
  • Presented new data on the safety and efficacy of EXPAREL across multiple surgical models: In May 2011 new data demonstrating the comprehensive, program-wide efficacy for EXPAREL was presented at the 2011 International Anesthesia Research Society (IARS) Annual Meeting and the Society for Ambulatory Anesthesia's (SAMBA) 26th Annual Meeting. The study examined the safety profile of EXPAREL in 823 patients across ten surgical site infiltration studies and five surgical procedures, including hemorrhoidectomy, bunionectomy, total knee arthroplasty, breast augmentation and hernia repair.
  • Presented new Phase 1 and preclinical data on EXPAREL: In May 2011 Pacira presented new Phase 1 and preclinical data on EXPAREL at the American Society of Regional Anesthesia and Pain Medicine's (ASRA) 36th Annual Regional Anesthesia Meeting and Workshops.
  • Appointed two life sciences industry veterans to the board of d
    '/>"/>

  • SOURCE Pacira Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related medicine technology :

    1. Pacira Pharmaceuticals, Inc. Announces Data Presentations at the 38th Annual Meeting & Exposition of the Controlled Release Society
    2. Pacira Pharmaceuticals, Inc. Announces Timing for Second Quarter 2011 Financial Results Webcast and Conference Call
    3. Pacira Pharmaceuticals, Inc. Announces Inclusion in Russell 3000 Index
    4. Pacira Pharmaceuticals, Inc. Announces FDA Extension of EXPAREL™ PDUFA Target Date by Three Months
    5. Pacira Pharmaceuticals, Inc. Appoints Two Life Sciences Industry Veterans to Its Board of Directors
    6. Pacira Pharmaceuticals, Inc. to Present at UBS Global Specialty Pharmaceuticals Conference
    7. Pacira Pharmaceuticals, Inc. Announces EXPAREL™ Data Presentations at the International Anesthesia Research Society 2011 Annual Meeting
    8. Pacira Pharmaceuticals, Inc. Announces Phase 3 EXPAREL™ Data Presentation at the American Society of Colon and Rectal Surgeons 2011 Annual Meeting
    9. Pacira Pharmaceuticals, Inc. Reports First Quarter 2011 Financial Results
    10. Pacira Pharmaceuticals, Inc. Announces EXPAREL™ Data Presentations
    11. Pacira Pharmaceuticals, Inc. Announces Timing for First Quarter 2011 Financial Results Webcast and Conference Call
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/1/2015)... July 1, 2015 Dynatronics Corporation (the ... marketer of rehabilitation and physical therapy products, announced ... placement financing led by affiliates of Prettybrook Partners ... focused on the healthcare industry. The financing provides ... and pursue potential strategic acquisitions.  ...
    (Date:7/1/2015)... -- Qiming Venture Partners, today announces the promotion of ... William has been with Qiming for nearly ... Qiming healthcare deals, and assisted many of these companies ... success in healthcare is not a small part from ... outstanding advocacy and service mentality on behalf of all ...
    (Date:7/1/2015)... Lupin , Strides ... MPP Sub-licensees to Fourteen Companies     ... expansion of its network of generic manufacturers to 14 companies ... antiretrovirals (ARVs). New companies Lupin and Strides Arcolab recently signed ... the MPP licensed from ViiV Healthcare two months after its ...
    Breaking Medicine Technology:Dynatronics Announces Completion Of $4,025,000 Private Placement Led By Prettybrook Partners 2Dynatronics Announces Completion Of $4,025,000 Private Placement Led By Prettybrook Partners 3Qiming Announces the Promotion of William Hu to Managing Partner 2The Medicines Patent Pool Increases its Generic Manufacturing Network to Ramp-Up Production of Low Cost Antiretrovirals (ARVs) 2The Medicines Patent Pool Increases its Generic Manufacturing Network to Ramp-Up Production of Low Cost Antiretrovirals (ARVs) 3
    ... announced today the company has reached another major milestone ... management team roster. DiFUSION Technologies is ... commercialization of its proprietary CleanFUZE ™ anti-microbial technology ... line of Posterior Interbody products. "In ...
    ... supplier of comprehensive patient management solutions, today introduced its ... TrendSetter collects patient compliance data from any brand of ... to home health providers. This allows the providers to ... Other solutions only work for single brands of PAP ...
    Cached Medicine Technology:DiFUSION Technologies Adds Accomplished Senior Management Team 2DiFUSION Technologies Adds Accomplished Senior Management Team 3DiFUSION Technologies Adds Accomplished Senior Management Team 4DiFUSION Technologies Adds Accomplished Senior Management Team 5
    (Date:7/2/2015)... ... July 02, 2015 , ... Scientists at ... nearly $4 million through five federal grants to study a group of related ... deadly diseases. , The research will be conducted in the Regional Biocontainment ...
    (Date:7/2/2015)... ... July 02, 2015 , ... ... healthcare providers, has been retained to lead a national chief operating officer ... executive search firms in the healthcare industry, B. E. Smith has recently placed ...
    (Date:7/2/2015)... ... July 02, 2015 , ... Evolved Ayurvedic Discoveries , ... an intention to partner with companies that share a similar mission of providing ... water soluble, Cannabidiol (CBD) formulations, combined with Ayurvedic herbs, are now available for ...
    (Date:7/2/2015)... ... ... A team of quality control (QC) experts at GE Healthcare, led by ... enhanced workflow. Now, Dr. Dunne’s lab has set a lofty goal: to become the ... network. , Join the team members for a new, free educational webinar ...
    (Date:7/2/2015)... ... July 02, 2015 , ... Cs &A, the ... Timing announced the release and publication of their newest offering to complement the ... and Newsletter. , Designed in support of coverage for the full spectrum ...
    Breaking Medicine News(10 mins):Health News:Mosquito-Borne Viruses Subject of $4M in Federal Grants to Scientists in Pitt’s Center for Vaccine Research 2Health News:Mosquito-Borne Viruses Subject of $4M in Federal Grants to Scientists in Pitt’s Center for Vaccine Research 3Health News:Mosquito-Borne Viruses Subject of $4M in Federal Grants to Scientists in Pitt’s Center for Vaccine Research 4Health News:Nicklaus Children’s Hospital Retains B. E. Smith to Recruit New Chief Operating Officer 2Health News:Nicklaus Children’s Hospital Retains B. E. Smith to Recruit New Chief Operating Officer 3Health News:New Water Soluble CBD Provides Manufacturers & Distributors a More Effective, Safe, & Cost Efficient Alternative to Traditional CBD Oil 2Health News:New Water Soluble CBD Provides Manufacturers & Distributors a More Effective, Safe, & Cost Efficient Alternative to Traditional CBD Oil 3Health News:GE Healthcare Webinar Spotlights GE’s Own, Internal QC Lab Enhancements with Six Sigma 2Health News:GE Healthcare Webinar Spotlights GE’s Own, Internal QC Lab Enhancements with Six Sigma 3Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 2Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 3Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 4
    ... in blood pressure, disease scores , , SUNDAY, March 30 ... electronically, good doctor-patient communication helps reduce the risk of ... study. , The four-year study included rural and urban ... were otherwise healthy. They were divided into two groups, ...
    ... agent that combines 2 medications , , SUNDAY, March 30 (HealthDay ... to make sense of a trial showing that a drug ... no apparent benefit to people at high risk of heart ... a well-known statin -- simvastatin -- with ezetimibe, which also ...
    ... In a comparison of anticoagulants and stents for use ... and tirofiban had similar outcomes for some cardiac measures ... received stents that released the drug sirolimus had a ... months than patients who received uncoated stents, according to ...
    ... restenosis risk and don,t increase mortality probability , , SUNDAY, ... tubing placed in diseased coronary arteries to keep them ... attack patients, new research shows. , In the largest ... -- the drug in question retards the growth of ...
    ... RN ... Organization, HOUSTON, March 29 ... a stronger voice to speak,out for patients and themselves, a northwest Houston ... bargaining,rights., RNs at Cypress Fairbanks Medical Center Hospital voted 119 to ...
    ... cancer deaths could be avoided with lifestyle changes, experts ... therapies that could cut cancer deaths in half. , ... recent American Cancer Society report that said as many ... with lifestyle changes, such as quitting smoking, maintaining a ...
    Cached Medicine News:Health News:Combining Internet With Office Visits Cut Heart Attack Risks 2Health News:Cholesterol Drug Controversy Continues 2Health News:Cholesterol Drug Controversy Continues 3Health News:Comparison of anticoagulants for angioplasty show similar outcomes 2Health News:Drug-Eluting Stents Safe After Heart Attack 2Health News:First Unionized Hospital in Texas 2Health News:First Unionized Hospital in Texas 3Health News:You May Be the Key to Cancer Prevention 2Health News:You May Be the Key to Cancer Prevention 3
    Chemically Resistant Sealing Mat for 96ch, 1.1ml or 2.0ml, Deep Well, Round Available Sterile...
    Sealing Mat for 96-well PCR Plate, Natural...
    MicroAmp Full Plate Covers, which are manufactured from PCR-compatible rubber, are non-sterile, autoclavable and guaranteed reusable up to five times....
    Omniseal TD mat. Reusable rubber mat for sealing PCR plates. 5 pk....
    Medicine Products: